US Stock MarketDetailed Quotes

CYTO Altamira Therapeutics

Watchlist
  • 1.2500
  • +0.0100+0.81%
Close Jun 18 16:00 ET
  • 1.2300
  • -0.0200-1.60%
Post 18:58 ET
2.80MMarket Cap-140P/E (TTM)

Altamira Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Altamira Therapeutics Earnings Date

Currency: CHF

Period

FY2023 Annual Report

Apr 10, 2024

Revenue(YoY)

0.00

0.00%
EPS(YoY)

-7.88

+98.65%
Analyst Rating

No Data

Altamira Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency:

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/H2-- / 0.000--
--2024/H1-- / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/H2-- / 0.000--
--2024/H1-- / 0.000--

Altamira Therapeutics Earnings Reports

  • Altamira Therapeutics | 20-F/A: Registration statement / Annual report / Transition report (Amendment)

    Apr 22 22:18 ET

  • Altamira Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

    Apr 16 17:01 ET

  • Altamira Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

    Apr 10 08:32 ET

  • Altamira Therapeutics | 20-F: Registration statement / Annual report / Transition report

    Apr 10 08:02 ET

    • Read more

    Analysis

    Analyst Rating

    No Data

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg